You are invited to take part in a study investigating new vaccines against Ebola virus disease (EVD). The current outbreak of EVD in West Africa is estimated by the World Health Organization to have caused more than 10,000 deaths to date and is still ongoing. There is no specific treatment or cure for Ebola and an effective vaccine would be an important step in controlling the spread of disease. The study is being run by the Oxford Vaccine Group, part of the University of Oxford.
► If you are aged 18 to 65 years old and in good health you may be eligible to take part in the study
► We will provide reimbursement for your time, inconvenience and travel
Interested individuals may attend a screening visit at our site to discuss this further and for their suitability for the study to be assessed. If you would like to find out more, you can contact us via:
This study is being run by the Oxford Vaccine Group, part of the University of Oxford and is funded by Crucell Holland BV.